We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 198,696 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/7/2019 08:38 | Well said, Featherby. It seems to me that regardless of the difficulties tiny companies face in bringing new drugs to market that N4P and Nuvec have never been in better shape:))) | ch1rp | |
06/7/2019 16:35 | The particles were loaded incorrectly by an outsourced laboratory, admittedly sounds very amateurish but it’s now thankfully forced a credible action plan to ensure the successful in vivo test can and will be replicated positively as it HAS done before and eliminating such mistakes to be repeated. It’s also worth noting this study will speed up additional studies with new collaborations starting on the strength of this work. Also fund raising is not an issue for the foreseeable future before anyone raises that problem, the budget for this upcoming works including manufacturing readiness at GMP standard which is critical for research growth is covered. Not one large shareholder has sold any shares I also must highlight. I’m honestly trying hard not to be that ramper type that everyone hates but I do have to endorse the positives and correct the inaccurate. | featherby81 | |
06/7/2019 16:09 | But the technology has failed once so you have to worry about reproducibility. I worked on many programs where good results were not repeatable. It is the nature of science... | nobbygnome | |
06/7/2019 15:59 | Current Market cap 5.3 million for what's on offer. | sbb1x | |
06/7/2019 11:52 | And those developers will be paying N4 upfront, no risk to N4. If successful further royalties roll in! It’s a takeout dream | featherby81 | |
06/7/2019 09:05 | Well said Featherby81. I feel exactly the same about the Nuvec/ Nuvec story and am well invested. What I found particularly appealing was the high calibre of professionals who developed a suite of drugs that if, in any one of them made it passed trials and to market would make vast global sales. In this world it costs miles of money and time to bring these drugs to market and a little company like this with rock solid patents are hopefully, slowly but surely bringing them to market. Nuvec was always their ace in the pack, few substitutes and already proven in certain tests. I hope N4 will prove Nuvec to the world. Doing so would also allow them the possibility to develop the other drugs they have in their portfolio and for a tiny company in this world of pharmaceutical giants that would indeed be something.Here's to the day when we all see massive returns on our investment here:))) | ch1rp | |
05/7/2019 22:19 | Nobby, you were absolutely spot on with Sildenafil and did warn the timings would be an issue sublingually. Nuvec is a totally different concept and only a very small few have technology with similarities but still are having trouble which N4 might eventually overcome. What N4 and UQ have developed is potentially a milestone in vaccine development, you couldn’t deny that. This early stage research is still a risk I admit and every investor ought to realise things can change in a split second, good or bad. Myself and a number or serious investors joined N4 for the Nuvec/Nuvac story alone , it could be life changing for anyone holding a few thousand shares so I am keen to see this through until either commercial success or bankruptcy. | featherby81 | |
05/7/2019 15:52 | Leopards don't change their spots, but discredited tosspots do change their Twitter and advfn names..! | dplewis1 | |
05/7/2019 15:34 | >> featherby I don't look at the thread very often as I am not invested any longer but maintain a historical interest so the timing of my posts is completely random. As you know there was one particular person who painted a completely naive and misleading story and I just gave the realistic, science based view. I will continue to do that and my perception is there is a massive risk here that essentially the company has a very unreliable technology which will never be fit for commercialisation. For me an awful lot of alarm bells have been ringing ever since the viagra disaster. Leopards don't change their spots.... | nobbygnome | |
05/7/2019 12:04 | Mmmm many more buys than sells but down 4 pc??? | ch1rp | |
05/7/2019 10:39 | Buyers coming in, should get to at least 10p before results | sbb1x | |
05/7/2019 10:09 | Last week we were talking about getting over 5p, well now it's here and maintaining a good base. This will build towards news whether Nobb wants it to or not:))) | ch1rp | |
05/7/2019 10:01 | You never post on a day it’s rising Nobby, not having a pop just wondering. | featherby81 | |
05/7/2019 09:40 | The price reflects the risk. The evidence suggests the technology is not reliable and so the jury is out. There is a real chance they will get equivocal results from the ongoing experiments in which case it's all over bar the shouting IMHO. Currently I wouldn't touch it with a barge pole.... | nobbygnome | |
05/7/2019 09:30 | Given the tech and the size of the future nano vaccine market (over $200b now possibly??) it wouldn’t be too boisterous to assume multiples of £100m mcap is what Nigel and crew are trying to eventually attain. It’s got a long way to go at current research stage but human trials will be the turning point for Nuvecs success, make or break!. | featherby81 | |
05/7/2019 09:00 | Market cap 5.5 million. If successful what's the value worth to the company.... | sbb1x | |
05/7/2019 08:45 | True, but it doesn't take away the fact that Nuvec has already passed the tests and results for the new batch of tests will be available in 2 months. Good news will rocket this share back to 30p and beyond. Watch as the BIG money buys in at these oversold levels:))) | ch1rp | |
04/7/2019 22:34 | Some Twitter chunt claiming he bagged massive when this same chunt was buying 8s and 9s before the April updateforgot about them buysstupid chunt likes to big up imself, innit | dailylarma | |
04/7/2019 09:50 | Slasher 81 on twitter yesterday This repeat test is extremely important as it provides the technical information (a handbook) for future collaborations or partners. If AZ or another huge player ain't showing interest before human trials begin it'll be THE share to be in!! #N4P | ch1rp | |
04/7/2019 08:44 | Cant see any reason for this rise.Watching with interest!!! | billthebank | |
04/7/2019 08:33 | Mms are fooling no one:))) | ch1rp | |
04/7/2019 08:29 | You buyin’ | escapetohome | |
04/7/2019 08:21 | Don't need any ramps of other stock here. | soupdragon55 | |
04/7/2019 07:49 | Folks get in wrks net debt of £24m reansformed into net cash of £2.9m 495 stores dirextors all bought in yesterday only 63m shares hashtag wrks twitter | aladin1033 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions